Patent Cases in the News. Who knew so many people cared? Law.com reports that "High Court Patent Case May Have Profound Business Impact." From the article: "The high stakes are reflected by the amicus parties in the case. The Bush administration, generic drug makers, and environmental groups who believe the decision could have impact beyond the patent field, are among those supporting MedImmune. Supporters of Genentech include leading pharmaceutical and biotechnology companies, colleges and universities, and the American Intellectual Property Law Association."